A remarkable new drug shows promise for treatment of patients with lung cancer who have a rare genetic mutation. Drugs, crizotinib, stabilised or improvement of disease in 90% of patients at an early stage clinical trial results, a study released Wednesday in the New England Journal of Medicine (NEJM).
"Some of our patients can see improvement in their symptoms in a few days or week," said Dr. Alice Shaw, one of the lead researchers of the drug. -The answers to these questions is dramatic.
Published research of samTrackback
No comments:
Post a Comment